Skip to main content
. 2013 Dec;3(4):862–869. doi: 10.1086/674762

Table 4.

Incidence of safety and tolerability events

Event Incidence Dose reduced Drug discontinued
Major events
 PGI2-associated cyanosis 2. (5.6) 2. (100)
 Significant bleeding event 2. (5.6)
Minor events
 Hypotension 7. (19.4) 5. (71.4) 1. (14.3)
 Pain 6. (16.7)
 Flushing 4. (11.1)
 Feeding intolerance 1. (2.8) 1. (100)
 Thrombocytopenia 0. (0)
Note

Data are no. (%). PGI2: prostacyclin.